Immunotherapy Archives - Page 3 of 3

Charles M. Perou, PhD, a UNC Lineberger member and a professor of genetics, pathology and laboratory medicine at the UNC School of Medicine, was a co-corresponding author of a study recognized by the Clinical Research Forum.

A cancer genomics study led by UNC Lineberger researchers and other scientists involved in The Cancer Genome Atlas (TCGA) project, a National Cancer Institute and National Human Genome Research Institute-backed effort to create a comprehensive atlas of the genetic changes in cancer, was selected as one of the top 10 clinical research achievements of the year. The project characterized molecular changes in 12 different cancers and revealed a new approach to classifying cancers.

UNC Lineberger Comprehensive Cancer Center researchers will share their study findings and expertise at the American Association for Cancer Research’s annual meeting, which is expected to draw thousands to Philadelphia April 18-22 to discuss advances in cancer science.

William Kim, MD, a UNC Lineberger member and an associate professor of medicine and genetics at the UNC School of Medicine, spoke on UNC’s findings of molecular subtypes of bladder cancer at UNC Lineberger's 39th annual symposium.

UNC Lineberger's 39th annual scientific symposium was held April 8-9 at the William and Ida Friday Center for Continuing Education in Chapel Hill.

Drs. Jon Serody, Gianpietro Dotti and Barbara Savoldo

Two new faculty members have joined the UNC Lineberger Comprehensive Cancer Center to help launch groundbreaking immunotherapy clinical trials that will test an experimental treatment in which patients’ own immune cells are genetically engineered to fight their cancer.

The Bladder Cancer Advocacy Network (BCAN) has awarded William Kim, MD, associate professor of medicine, urology, and genetics, University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center, with the 2014 Bladder Cancer Research Innovation Award to support his project “Immune Characterization of High-Grade Bladder Cancer.”

The push and pull of physical force can cause profound changes in the behavior of a cell. Two studies from researchers working at the UNC Lineberger Comprehensive Cancer Center reveal how cells respond to mechanical manipulation.

Five questions for Yisong Wan, PhD, a new Jefferson-Pilot fellow who is uncovering the roles of T cells in disease cures and causes.

William Zamboni, PharmD, PhD, has developed a probe to measure the body’s immune function to help physicians deliver accurate, individualized doses for cancer patients prescribed nanoparticle-based drugs

The five-year grant recognizes the nation’s most innovative young scientists.

Tag: Immunotherapy

Clinical Research Forum selects genomic analysis as top 10 research achievement

UNC Lineberger members to share research, expertise at 2015 AACR meeting

Cancer genetics the focus of UNC Lineberger symposium

New UNC Lineberger faculty recruited to launch T-cell cancer therapy trials

Kim receives 2014 Bladder Cancer Research Innovation Award

Studies examine the role of physical force on cells

Five Questions for Yisong Wan: Understanding our immunity

Probe measuring immune function can be used to determine nanoparticle dosage for patients

Lineberger member receives Packard Fellowship in Science and Engineering